Announcement for DISS2023
Dear Staff & Students,
We are happy to announce the Duke-Industry Statistics Symposium (DISS), which will be held virtually March 29-31, 2023 with the theme “Empower Clinical Development by Harnessing Data from Diverse Sources”.
Clinical development commonly incorporates qualitative information outside of clinical trial settings in treatment evaluations and clinical assessments. Such qualitative information includes prior clinical experience and expert opinions. More recently, new study designs and methods that allow systematically harnessing information from diverse sources of external data, have been proposed. Leveraging external data sources, from historical trials in similar patient populations or with same class treatments to real-world data and real-world evidence, is expected to drastically improve the efficiency of clinical developments.
For information about the program schedule, including short courses, speakers, talk abstracts, poster submission, and registration, please visit the DISS2023 Website. The first day of the virtual symposium will be devoted to short courses. The following day and a half will consist of keynote speeches, parallel sessions, and poster lightning talk sessions. Dr. John Concato, the Associate Director for Real-World Evidence Analytics in the Office of Medical Policy, FDA/CDER, will give
a keynote speech on Regulatory Perspectives on Real-World Data on March 30. Dr. Demissie Alemayehu, the Vice President of Pfizer Biostatistics, will give the second keynote speech on March 31 on Enhancing Generalizability of Clinical Trial Results through Use of Real-World Evidence and Digital Solutions to Improve Enrollment Diversity.
The virtual symposium will be free for undergraduate and graduate students with majors in statistics, biostatistics, and data sciences. Students should email Judy Adkins at judy.adkins@duke.edu with their viable credentials to request a student promo code. We are encouraging poster submissions for the symposium. The poster lightning talk sessions offer a great opportunity for graduate students or young researchers to share their research work. The poster can be any topic that involves the use of quantitative methods in pharmaceutical developments.
DISS2023 Poster Lightning Talk Session
The DISS2023 is pleased to invite submissions for poster lightning talks and poster award competitions. The poster lightning talk session provides an excellent opportunity to allow the presenters to introduce their work and have virtual interactions with the audience. Topics that involve the use of quantitative methods in pharmaceutical developments are preferred. Posters that have been presented before at other conferences are acceptable.
1. An electronic version poster or slides with less than 10 pages are both accepted formats.
2. All posters or slides will be uploaded to conference website one week before the conference.
3. Virtual poster lightning talk session is 12:00-1:30pm on March 30, 2023. Each presenter has 5 minutes to pitch their project.
4. Virtual interaction time will be arranged for presenters and audience right after the session.
Poster Submission
The deadline to submit a e-poster/slides is March 15, 2023 5:00pm to ensure your poster is available online for download before the conference and be considered for award. To submit, please send your poster with subject line “Poster submission for DISS2023” to both Dr. Hwanhee Hong at hwanhee.hong@duke.edu and Dr. Marlina Nasution at marlina.nasution@parexel.com
Poster Awards
Any poster or slides that is submitted by March 15, 2023 5:00pm will be considered for poster awards. Posters will be evaluated by the poster committee based on its scientific merit and presentation. One to two poster award winners will be selected and will be announced at the keynote session on Friday March 31, 2023. Each winner will receive a prize and an award certificate.
